Development of anti-SARS-CoV-2 vaccines

Key facts

Disease
COVID-19
Funder
ANR
Principal Investigator
Véronique GODOT
Research Location
France
Lead Research Institution
Institut Mondor de Recherche Biomédicale - IMRB
Research Priority Alignment
N/A

Research Category
Vaccines research, development and implementation
Research Subcategory
Pre-clinical studies
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

The DC-CoVaC project, coordinated by Véronique Godot (UMR U955 Mondor Institute for Biomedical Research - IMRB), aims to test the immunogenicity and the preventive effect of a combination of two vaccine platforms in phase 1 to 3 of clinical development. Their approach aims to induce a polyepitopic T and B cell response. The vaccines will be tested in two preclinical models in order to study in vivo human immune responses induced by vaccines, and to demonstrate the protective effect of these vaccines.

Publicationslinked via Europe PMC

Last Updated:2 days ago

View all publications at Europe PMC

Development and Validation of the Intimate Partner Violence Workplace Disruptions Assessment (IPV-WDA).

Elucidating directed neural dynamics of scene construction across memory and imagination

Implementing a Novel Resident-Led Peer Support Program for Emergency Medicine Resident Physicians.

Cross-Activity Analysis of CRISPR/Cas9 Editing in Gene Families of <i>Solanum lycopersicum</i> Detected by Long-Read Sequencing.

Creating health systems citizens: enhanced professional identity formation through a para-curricular distinction track in health systems transformation and leadership.

A Comparison of Clinical Diagnostic Classification Criteria Used in Longitudinal Cohort Studies of the Alzheimer's Disease Continuum: A Systematic Review.